CORCEPT THERAPEUTICS INC - 021835210

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q2 2014 · Compare: Q1 2014
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
INGALLS & SNYDER LLC History Added to 6,655,073 18,633 0.92% 1.52% 1 +155,620 2.39% Q2 2014 Jul 30, 2014